September 26, 2017 marked the day Stelvio joined Johnson & Johnson Innovation JLABS in San Diego, California. This vibrant ecosystem is a catalyst for innovation with a capital efficient no strings attached business model. This enables Stelvio to focus on it's mission to deliver innovative medicines of value to patients and being a resident of JLABS provides exposure to key deal makers for R&D collaborations.
https://jlabs.jnjinnovation.com/companies/featured-residents/stelvio-therapeutics